Astrazeneca (AZN) Net Shares Issued and Repurchased (2009 - 2012)

Astrazeneca's Net Shares Issued and Repurchased history runs 4 years deep, the most recent figure standing at -$2.2 billion for Q4 2012.

• In Q4 2012, Net Shares Issued and Repurchased rose 60.65% year-over-year to -$2.2 billion; the TTM figure through Dec 2012 stood at -$11.2 billion (down 21.58% YoY), while the FY2012 annual figure was -$2.6 billion, up 56.19% from the prior year.
• Net Shares Issued and Repurchased for Q4 2012 stood at -$2.2 billion, up from -$5.6 billion in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $135.0 million in Q4 2009, with the low at -$5.6 billion in Q4 2011.
• The 4-year median for Net Shares Issued and Repurchased is -$1.7 billion (2010), against an average of -$1.9 billion.
• The sharpest annual moves came in 2010 and 2012: Net Shares Issued and Repurchased sank 1662.96% in 2010, then surged 60.65% in 2012.
• Astrazeneca's Net Shares Issued and Repurchased stood at $135.0 million in 2009, then tumbled by 1662.96% to -$2.1 billion in 2010, then tumbled by 165.69% to -$5.6 billion in 2011, then soared by 60.65% to -$2.2 billion in 2012.
• Business Quant data shows AZN's Net Shares Issued and Repurchased at -$2.2 billion in Q4 2012, -$5.6 billion in Q4 2011, and -$1.3 billion in Q1 2011.